Chronic granulomatous disease - PubMed (original) (raw)
Review
Chronic granulomatous disease
M C Dinauer et al. Annu Rev Med. 1992.
Abstract
Chronic granulomatous disease (CGD) encompasses a group of rare inherited disorders characterized by defects in a phagocyte-specific NADPH-oxidase complex that forms the superoxide radical during the respiratory burst. In this chapter, the protein components and cellular biochemistry of the oxidase are reviewed in light of recent genetic and biochemical studies of CGD. The classification and molecular genetic analysis of CGD is discussed. Finally, the use of recombinant human interferon-gamma as a new therapeutic agent for management of the disorder is reviewed.
Similar articles
- Molecular basis of the autosomal recessive forms of chronic granulomatous disease.
Curnutte JT. Curnutte JT. Immunodefic Rev. 1992;3(2):149-72. Immunodefic Rev. 1992. PMID: 1554499 Review. - The respiratory burst oxidase and the molecular genetics of chronic granulomatous disease.
Dinauer MC. Dinauer MC. Crit Rev Clin Lab Sci. 1993;30(4):329-69. doi: 10.3109/10408369309082591. Crit Rev Clin Lab Sci. 1993. PMID: 8110374 Review. - Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.
Newburger PE, Ezekowitz RA. Newburger PE, et al. Hematol Oncol Clin North Am. 1988 Jun;2(2):267-76. Hematol Oncol Clin North Am. 1988. PMID: 2839459 - Chronic granulomatous disease: diagnosis and classification at the molecular level.
Hopkins PJ, Bemiller LS, Curnutte JT. Hopkins PJ, et al. Clin Lab Med. 1992 Jun;12(2):277-304. Clin Lab Med. 1992. PMID: 1611821 Review. - Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
Ezekowitz RA, Orkin SH, Newburger PE. Ezekowitz RA, et al. J Clin Invest. 1987 Oct;80(4):1009-16. doi: 10.1172/JCI113153. J Clin Invest. 1987. PMID: 2821069 Free PMC article.
Cited by
- NADPH oxidases in heart failure: poachers or gamekeepers?
Zhang M, Perino A, Ghigo A, Hirsch E, Shah AM. Zhang M, et al. Antioxid Redox Signal. 2013 Mar 20;18(9):1024-41. doi: 10.1089/ars.2012.4550. Epub 2012 Aug 27. Antioxid Redox Signal. 2013. PMID: 22747566 Free PMC article. Review. - Targeting fundamental pathways to disrupt Staphylococcus aureus survival: clinical implications of recent discoveries.
Thomsen IP, Liu GY. Thomsen IP, et al. JCI Insight. 2018 Mar 8;3(5):e98216. doi: 10.1172/jci.insight.98216. JCI Insight. 2018. PMID: 29515041 Free PMC article. Review. - Tactics of Mycobacterium avium subsp. paratuberculosis for intracellular survival in mononuclear phagocytes.
Woo SR, Czuprynski CJ. Woo SR, et al. J Vet Sci. 2008 Mar;9(1):1-8. doi: 10.4142/jvs.2008.9.1.1. J Vet Sci. 2008. PMID: 18296882 Free PMC article. Review. - Identification of a region in p47phox/NCF1 crucial for phagocytic NADPH oxidase (NOX2) activation.
Sareila O, Jaakkola N, Olofsson P, Kelkka T, Holmdahl R. Sareila O, et al. J Leukoc Biol. 2013 Mar;93(3):427-35. doi: 10.1189/jlb.1211588. Epub 2012 Dec 27. J Leukoc Biol. 2013. PMID: 23271700 Free PMC article. - Very early-onset inflammatory bowel disease: gaining insight through focused discovery.
Moran CJ, Klein C, Muise AM, Snapper SB. Moran CJ, et al. Inflamm Bowel Dis. 2015 May;21(5):1166-75. doi: 10.1097/MIB.0000000000000329. Inflamm Bowel Dis. 2015. PMID: 25895007 Free PMC article. Review.